Skip to main content
Article
Eribulin Plus Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase 1b/2 Study
Clinical Cancer Research
  • Grace Wang, Miami Cancer Institute
Publication Date
6-1-2021
Content Type
application/pdf
PubMed ID:
33727258
Additional Authors:

Additional authors and institutional affiliations

Citation Information

Clinical Cancer Research (2021) 27(11):3061-3068.